These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7514026)

  • 1. Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.
    Schlichtholz B; Trédaniel J; Lubin R; Zalcman G; Hirsch A; Soussi T
    Br J Cancer; 1994 May; 69(5):809-16. PubMed ID: 7514026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum anti-p53 autoantibodies in primary resected non-small-cell lung carcinoma.
    Iizasa T; Fujisawa T; Saitoh Y; Hiroshima K; Ohwada H
    Cancer Immunol Immunother; 1998 Aug; 46(6):345-9. PubMed ID: 9756419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: a prospective study.
    Segawa Y; Kageyama M; Suzuki S; Jinno K; Takigawa N; Fujimoto N; Hotta K; Eguchi K
    Br J Cancer; 1998 Sep; 78(5):667-72. PubMed ID: 9744508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
    Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
    Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: towards a paraneoplastic immune marker.
    Michils A; Lambert JP; Yernault JC; Fabry V; Gossart B; Duchateau J
    Cancer; 1996 Feb; 77(4):657-64. PubMed ID: 8616757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of quantitative serum p53 protein in lung cancer.
    Sen E; Gönüllü U; Akar N
    Tuberk Toraks; 2005; 53(3):231-7. PubMed ID: 16258881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface.
    Lubin R; Schlichtholz B; Bengoufa D; Zalcman G; Trédaniel J; Hirsch A; Caron de Fromentel C; Preudhomme C; Fenaux P; Fournier G; Mangin P; Laurent-Puig P; Pelletier G; Schlumberger M; Desgrandchamps F; Le Duc A; Peyrat JP; Janin N; Bressac B; Soussi T
    Cancer Res; 1993 Dec; 53(24):5872-6. PubMed ID: 8261396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
    Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
    Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
    Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
    Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lung.
    Komiya T; Hirashima T; Takada M; Masuda N; Yasumitsu T; Nakagawa K; Hosono Y; Kikui M; Tsuji S; Fukuoka M; Kawase I
    Anticancer Res; 1997; 17(5B):3721-4. PubMed ID: 9427768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum p53 antibodies as early markers of lung cancer.
    Lubin R; Zalcman G; Bouchet L; Trédanel J; Legros Y; Cazals D; Hirsch A; Soussi T
    Nat Med; 1995 Jul; 1(7):701-2. PubMed ID: 7585154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-p53 antibodies in patients with lung cancer.
    Mack U; Ukena D; Montenarh M; Sybrecht GW
    Oncol Rep; 2000; 7(3):669-74. PubMed ID: 10767388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients.
    Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY
    Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment.
    Zalcman G; Schlichtholz B; Trédaniel J; Urban T; Lubin R; Dubois I; Milleron B; Hirsch A; Soussi T
    Clin Cancer Res; 1998 Jun; 4(6):1359-66. PubMed ID: 9626451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227.
    Shitara K; Hanai N; Yoshida H
    Anticancer Res; 1993; 13(3):579-86. PubMed ID: 7686360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy.
    Bergqvist M; Brattström D; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Wagenius G; Brodin O
    Anticancer Res; 1998; 18(3B):1999-2002. PubMed ID: 9677456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of circulating anti-p53 antibodies in patients with advanced non-small cell lung cancer and their correlation to clinical parameters and survival.
    Bergqvist M; Brattström D; Larsson A; Hesselius P; Brodin O; Wagenius G
    BMC Cancer; 2004 Sep; 4():66. PubMed ID: 15367333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of the anti-p53 antibody response in malignant and benign pancreatic disease.
    Marxsen J; Schmiegel W; Röder C; Harder R; Juhl H; Henne-Bruns D; Kremer B; Kalthoff H
    Br J Cancer; 1994 Nov; 70(5):1031-4. PubMed ID: 7947080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPLUNC1 Is a Significant Marker in Pleural Effusion from Lung Cancer Compared to Tuberculosis.
    Xue JL; Yi L; Yan ZH; Li X; Wang XJ; Wei PJ; Zeng JE; Zhao YL; Zhang HT
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):206-12. PubMed ID: 26090599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma thymosin-alpha1 levels in lung cancer patients.
    Sasaki H; Fujii Y; Masaoka A; Yamakawa Y; Fukai I; Kiriyama M; Saito Y; Matsui H
    Eur J Cardiothorac Surg; 1997 Dec; 12(6):885-91. PubMed ID: 9489875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.